The Journal of Experimental Medicine · 2018 · 237 citations · 11 references
MedicineCancer BiologyOncologyCancer ImmunologyMolecular OncologyTranslational OncologyCancer ImmunotherapyImmunotherapy For Genitourinary CancersKidney CancerRenal Cell CarcinomaRenal DiseaseTranslational Cancer ResearchKidney Cancer RadiotherapyKidney Cancer SurgeryMetastatic Renal Cell Carcinoma TherapyRenal Cell Carcinoma Systemic TherapyTargeted Molecular TherapyTranslational Oncology Drug Development
Chris Boshoff, Senior Vice President of Immuno-Oncology, Translational and Early Development at Pfizer, and colleagues Samra Turajlic and Charles Swanton from the Francis Crick Institute and University College London give us their personal point of view on new insights and future therapeutic approaches for renal cancer.
11
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
Robert J. Motzer, Bernard Escudier, Saby George et al. · New England Journal of Medicine · 2015 · 5.9K citations · Full text
Medicine, Oncology, Pharmacotherapy +17
Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma
Diana Miao, Claire A. Margolis, Wenhua Gao et al. · Science · 2018 · 1.3K citations · Full text
David F. McDermott, Mahrukh Huseni, Michael B. Atkins et al. · Nature Medicine · 2018 · 1.3K citations · Full text
Medicine, Oncology, Pharmacology +17
Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal
Samra Turajlic, Hang Xu, Kevin Litchfield et al. · Cell · 2018 · 875 citations · Full text
Medicine, Cancer Biology, Oncology +17